<DOC>
	<DOCNO>NCT02173886</DOCNO>
	<brief_summary>This study conduct evaluate body absorbs process sustain release ( SR ) extend release ( XL ) medication bupropion ( WellbutrinÂ® ) . Subject 1-3 year post gastric bypass surgery invite participate . Non-surgical control also enrol base match criterion post gastric bypass subject . Participants ask complete two 12-hour study day approximately 11 day apart .</brief_summary>
	<brief_title>A Comparison Sustained Extended Release Bupropion Following Bariatric Surgery</brief_title>
	<detailed_description />
	<mesh_term>Bupropion</mesh_term>
	<criteria>1 . Male Female 2 . Age 1865 ( inclusive , time informed consent ) 3 . No tobacco use past three month . 4 . Underwent RouxenY Gastric Bypass weight loss surgery 1236 month prior study OR weight loss surgery match gastric bypass patient age , gender , BMI . 5 . Ability read , write understand English 1 . Taking medication clinically significant interaction bupropion interaction may alter study data . 2 . Hypersensitivity bupropion excipient contain within dosage form . 3 . Inability tolerate repeat blood draw . 4 . Any history bipoloar disorder psychotic disorder . 5 . Current major depressive disorder current suicidality . 6 . Alcohol substance dependence past year . 7 . Currently pregnant lactate unwillingness use medically accept contraception study 8 . Taking medication significantly alter gastrointesinal transit time significantly reduce acid secretion ( e.g . routine use proton pump inhibitor , H2 antagonists , sucralfate ) . 9 . Medical conditon may increase participant risk bupropion ( e.g. , history significant head injury , seizure disorder , etc . ) 10 . Self report history viral hepatits HIV . 11 . Positive urine drug screen unless document prescription noninteracting medication . 12 . History seizure epilepsy condition may increase seizure risk bupropion describe package insert ( e.g . history significant head injury , alcoholism , etc ) . 13 . History eat disorder anorexia nervosa bulimia . 14 . Renal impairment evidence estimate glomerular filtration rate le 60 ml/min/1.73 m2 report laboratory , abnormality renal panel medical provider feel put participant risk may compromise study data 15 . Hepatic insufficiency define hepatic enzyme great 3x upper limit normal hepatic laboratory abnormality discretion medical provider . 16 . Any significant electrolyte abnormality basic metabolic panel medical provider feel may put subject risk seizure bupropion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>